• Thumbnail

    April issue out now!

    Feat: The future of digital in pharma; Drugs that track adherence; New medical device regulations; 2018's most important IP cases

  • iPharma

    What's next for digital in pharma?

  • Digital sensor medicines: the holy grail in adherence?

    Will drugs that track adherence when ingested be a tough pill for patients to swallow?

  • The Pharma Fast 50

    PharmaTimes presents Alantra’s annual look at the fastest-growing pharma companies

  • Finalists announced!

    Following a meeting of the executive steering group, PharmaTimes Media is delighted to reveal the 2018 International Clinical Researcher of the Year finalists...

News

View all
Thumbnail image for Shire turns down Takeda’s advances

Shire turns down Takeda’s advances

Shire has now confirmed that it has thus far rejected three merger proposals from Takeda, the last one being valued at around $44 billion.

20th April 2018

Thumbnail image for FDA advisors back approval of GW’s Epidiolex

FDA advisors back approval of GW’s Epidiolex

As expected, an FDA advisory panel has backed approval of GW Pharmaceuticals/Greenwich Bioscience’s Epidiolex for treating seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.

20th April 2018

Thumbnail image for US widens use of AZ’ Tagrisso in lung cancer

US widens use of AZ’ Tagrisso in lung cancer

AstraZeneca’s Tagrisso has been approved in the US as a first-line treatment for patients with metastatic non-small-cell lung cancer whose tumours have epidermal growth factor receptor (EGFR) mutations.

20th April 2018

Web Exclusives

View all
Thumbnail image for Patient Files: Niemann-Pick type C

Patient Files: Niemann-Pick type C

After having two of their children diagnosed with NP-C, Phil and Andrea Marella set up a charity to help find a cure for this devastating neurodegenerative disease

Thumbnail image for SmartPeople: Mark Samuels

SmartPeople: Mark Samuels

The industry veteran talks about how he’s helping to change drug discovery as chief business and strategy officer of the new Medicines Discovery Catapult

Thumbnail image for Patent pending

Patent pending

A look at some of the most important pharma IP cases from the past year and the rest of 2018

Thumbnail image for The new power brokers

The new power brokers

How pharma should adapt to changes in the NHS that are impacting decision-making in primary care

Thought Leadership

View all
Thumbnail image for Making digital engagement truly patient-centric

Making digital engagement truly patient-centric

Digitally-augmented multi-channel engagement has proved to be a useful approach for working with patients. However, it is easy for  developers to default to a patient-facing website or an app that looks good and sounds impressive, but in practice doesn’t supply what patients want and need

Thumbnail image for PharmaMar, an innovative oncology company

PharmaMar, an innovative oncology company

PharmaMar is one of the few biopharmaceutical companies to have a product on the market, another awaiting commercialisation and various more at different stages of clinical development

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download